KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Amortization of Deferred Charges (2017 - 2026)

Emergent BioSolutions has reported Amortization of Deferred Charges over the past 10 years, most recently at $1.8 million for Q1 2026.

  • For Q1 2026, Amortization of Deferred Charges fell 21.74% year-over-year to $1.8 million; the TTM value through Mar 2026 reached $9.3 million, up 232.14%, while the annual FY2025 figure was $9.8 million, 32.43% up from the prior year.
  • Amortization of Deferred Charges for Q1 2026 was $1.8 million at Emergent BioSolutions, down from $2.6 million in the prior quarter.
  • Over five years, Amortization of Deferred Charges peaked at $8.9 million in Q2 2023 and troughed at -$6.7 million in Q3 2024.
  • A 5-year average of $2.6 million and a median of $2.3 million in 2025 define the central range for Amortization of Deferred Charges.
  • Biggest five-year swings in Amortization of Deferred Charges: surged 790.0% in 2023 and later crashed 217.54% in 2024.
  • Year by year, Amortization of Deferred Charges stood at $1.0 million in 2022, then skyrocketed by 470.0% to $5.7 million in 2023, then tumbled by 61.4% to $2.2 million in 2024, then grew by 18.18% to $2.6 million in 2025, then plummeted by 30.77% to $1.8 million in 2026.
  • Business Quant data shows Amortization of Deferred Charges for EBS at $1.8 million in Q1 2026, $2.6 million in Q4 2025, and $2.5 million in Q3 2025.